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Abstract
Background: Self-tests, tests on body materials to detect medical conditions, are widely available to the general
public. Self-testing does have advantages as well as disadvantages, and the debate on whether self-testing should
be encouraged or rather discouraged is still ongoing. One of the concerns is whether consumers have sufficient
knowledge to perform the test and interpret the results. An online decision aid (DA) with information on self-
testing in general, and test specific information on cholesterol and diabetes self-testing was developed. The DA
aims to provide objective information on these self-tests as well as a decision support tool to weigh the pros and
cons of self-testing. The aim of this study is to evaluate the effect of the online decision aid on knowledge on self-
testing, informed choice, ambivalence and psychosocial determinants.
Methods/Design: A single blind randomised controlled trial in which the online decision aid ‘zelftestwijzer’ is
compared to short, non-interactive information on self-testing in general. The entire trial will be conducted online.
Participants will be selected from an existing Internet panel. Consumers who are considering doing a cholesterol or
diabetes self-test in the future will be included. Outcome measures will be assessed directly after participants have
viewed either the DA or the control condition. Weblog files will be used to record participants’ use of the decision
aid.
Discussion: Self-testing does have important pros and cons, and it is important that consumers base their decision
whether they want to do a self-test or not on knowledge and personal values. This study is the first to evaluate
the effect of an online decision aid for self-testing.
Trial registration: Dutch Trial Register: NTR3149
Background
Self-tests on body materials are widely available to the
general public [1,2]. These tests give consumers the
opportunity to test themselves on medical conditions
without consulting a health professional first. Self-tests
are available for conditions such as diabetes, high cho-
lesterol, kidney disorders, Chlamydia or prostate cancer
[1,2]. In a recent study among Dutch Internet users,
18% of the respondents had ever performed a self-test
and 66% of all respondents considered to use a self-test
in the future [3]. Tests can be performed at home
(’home tests’), in which the consumer is responsible for
all aspects of the test: performing the self-test, interpre-
tation of the test-result and follow-up behaviour. These
tests can be bought on the Internet and are available in
drugstores or pharmacies. Other ways of self-testing are
‘streetcorner’ tests, in which a test is performed by
trained personnel in public places (for example in a
supermarket), or ‘direct access’ and ‘home collect’ tests,
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in which a sample is taken at a laboratory or at home, is
analysed in a laboratory and the results are sent to the
consumer by mail or email.
Self-testing does have advantages as well as disadvan-
tages, and the debate on whether self-testing should be
encouraged or rather discouraged is still ongoing [4-7].
Self-testing can be considered as an easy way for consu-
mers to gain more insight in their health status, it might
lead to early detection of disease, and fits in with our
current views on patient autonomy. On the other hand,
there are concerns about self-testing, for example
whether consumers have sufficient knowledge to enable
appropriate use of self-tests, such as insight in indica-
tions for testing, and whether they consider the possibi-
lity of obtaining false positive or false negative results.
Consumers who perform a self-test often perform these
tests for reassurance, because the test is offered by an
organisation at no costs, or out of curiosity [8,9], and
respond quite straightforward to the test result: they
generally have a high level of confidence in self-tests,
visit a doctor in case of an abnormal test result and are
reassured by a negative test result [2,9]. Consumers with
an intention towards self-testing also perceive these ben-
efits of self-testing, although they experience several bar-
riers as well, such as doubts concerning the reliability of
self-tests and not knowing how to interpret the test
result (Grispen et al: An intention to self-testing: a qua-
litative study regarding consumers’ considerations and
information needs about self-testing, submitted)
To support consumers in deciding whether they want
to perform a self-test or not, objective information on
self-tests could be provided to stimulate consumers to
weigh the pros and cons of self-testing. Their decision
should be based on knowledge as well as personal
values, in which these personal values are related to
intention, for example, a positive attitude should lead to
a positive intention; a so-called informed choice. Consu-
mers with an intention towards self-testing indicated
they experienced benefits as well as barriers in self-test-
ing. In other words, they experienced feelings of ambiva-
lence towards self-testing [10]. If these feelings are not
resolved and people have to make a decision, they
experience feelings of discomfort. Therefore, ambivalent
attitude holders have the urge to integrate these feelings
into one response; they want to ‘choose sides’ [10]. To
support patients in making a choice that is the best
choice in their specific situation, for example for
patients facing treatment and screening decisions, deci-
sion aids have been developed. These decision aids have
shown to improve people’s knowledge of options and
reduce difficulty in decision making [11].
We developed a web-based decision aid on self-testing
http://www.zelftestwijzer.nl, which provides information
on self-tests in general, and test specific information on
self-tests for diabetes and cholesterol. The web-based
decision aid was based on clinical practice guidelines,
previous research on self-testing [3,9,12,13], the Interna-
tional Patient Decision Aid Standard (IPDAS) [14,15],
and the Health Belief Model (HBM) [16]. The decision
aid provides information on self-testing, as well as a
value clarification tool to weigh the pros and cons of
self-testing. The aim of this study is to investigate the
effect of the web-based decision aid on knowledge of
self-testing, informed choice, ambivalence and psychoso-
cial concepts.
Theoretical framework
Health Belief Model
The Health Belief Model (HBM) [16] was used as the
theoretical framework during the development of the
decision aid and will be used in its evaluation as well.
According to the HBM, an individual’s decision to
engage in health-related behaviour is based on their eva-
luation of the severity of and the susceptibility to a par-
ticular condition or illness and the belief that a certain
action is effective in reducing their susceptibility to or
the severity of this condition. Furthermore, individuals
are only inclined to engage in health-related behaviour
if they perceive more benefits than barriers associated
with that behaviour and if certain cues (for example in
self-testing: having a neighbour with diabetes, or the
offering of free tests) are present that trigger action.
Finally, self-efficacy, the individual’s confidence in his or
her capability to successfully perform a certain action, is
an important concept within the HBM.
Besides the concepts of the HBM, additional concepts
of the Theory of Planned Behaviour (TPB) [17] were
used in the development and evaluation of the decision
aid, namely subjective norm, anticipated regret, moral
obligation and response efficacy. These concepts have
been shown to contribute to the explanation of health-
related behaviour [18-22].
Ambivalence
In previous research we found that individuals who
intend to perform a cholesterol or diabetes self-test per-
ceived strong benefits as well as strong barriers towards
using a self-test (Grispen et al: An intention to self-test-
ing: a qualitative study regarding consumers’ considera-
tions and information needs about self-testing,
submitted). Individuals who hold both strong positive
and negative beliefs or feelings towards a certain action
or attitude object are considered to be ambivalent [10].
An important distinction needs to be addressed con-
cerning the ambivalence concept, namely the difference
between potential ambivalence [23] and felt ambivalence
[24]. Potential ambivalence concerns the coexistence of
beliefs that are associated with incongruent evaluations
related to a certain behaviour or attitude object.
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Individuals do not necessarily have to be aware of this
incongruence and therefore potential ambivalence can
be implicit. Felt ambivalence refers to simultaneously
having positive and negative emotions towards a certain
behaviour or attitude object. For felt ambivalence to
occur, the individual needs to be aware of his conflicting
feelings between the two sides of the behaviour or atti-
tude object. These conflicting feelings lead to psycholo-
gical discomfort which is experienced as being
unpleasant. Ambivalent attitude holders are motivated
to solve this psychological discomfort by integrating
their conflicting feelings in one evaluate response. When
this is achieved, ambivalence and the related psychologi-
cal discomfort are solved [10,25].
Study aim and research questions
The principal aim of the proposed study is to evaluate
the effect of the decision aid on knowledge of on self-
testing. The following research questions were
formulated:
1. Do consumers who have been exposed to the deci-
sion aid have more knowledge of self-testing than the
control group?
2. Do consumers who have been exposed to the deci-
sion aid more often make an informed choice in self-
testing than consumers in the control group?
3. Do the intervention and control groups differ in
level of attitudinal ambivalence?
4. What is the effect of the decision aid on the psy-
chosocial factors that predict self-test use for diabetes
and cholesterol?
5. Is there a difference between the intervention and
control group in follow-up behaviour 3 months after the
use of the decision aid?
Methods/Design
Study design
A single-blind randomised controlled trial in which the
online decision aid will be compared to short, non-inter-
active information on self-testing in general (non-test-
specific). The entire trial will be conducted online.
Ethical approval
The study was reviewed by The Medical Ethical Com-
mittee of Maastricht University Medical Centre. They
had no objection to the study proceeding and because
the study evaluates usual care and no patient recruit-
ment was required, formal approval was not deemed
necessary.
Setting and participants
Participants will be recruited from an existing Internet
panel in the Netherlands that is managed by Flycatcher,
an ISO-certified institute for online research associated
with Maastricht University. Currently, the panel consists
of approximately 14,000 active members between 12
and 96 years of age http://www.flycatcher.eu. Members
of the panel are recruited online, by written invitation,
face to face contacts or by intermediaries. All individuals
aged 12 years or older and who have an email address
can apply for the panel. Compared with the Dutch
population, the panellists are younger, have a higher
level of education and are more often female. The total
panel is representative of the Dutch Internet population.
Panel members receive invitations to participate in
online questionnaires approximately eight times per
year, and receive an incentive when they have completed
a certain number of questionnaires. Variables of the
panel members such as age, sex and level of education
are provided by Flycatcher.
Inclusion and exclusion criteria
Panel members aged 18 or older, with an intention to
use a diabetes and/or a cholesterol self-test in the future
will be invited to participate in the randomised con-
trolled trial. An intention will be defined as a consumer
indicating to maybe, probably, or definitely intending to
use a self-test in the future. People who report that they
are already diagnosed with diabetes and/or a cardiovas-
cular disease will be excluded from this study.
Randomisation
Participants will be assigned to one of two groups (hav-
ing an intention towards doing a cholesterol or towards
doing a diabetes self-test). If participants have an inten-
tion to do both, they will be assigned to the test towards
which they have the strongest intention. Within each
group, randomisation over experimental conditions (and
invitation to view either the decision aid or the control
condition) will be performed by Flycatcher using SPSS.
Participants will be blinded for randomisation.
Intervention
The HBM [16], IPDAS criteria [14,15] and the results of
previous quantitative and qualitative studies [3,9,12,13]
provided input for the development of the decision aid
http://www.zelftestwijzer.nl. The medical information in
the decision aid is based on current clinical practice
guidelines on screening for diabetes and cardiovascular
disease. After the first versions of the decision aid had
been developed, the content and usability of the decision
aid were assessed by professionals as well as by end
users. An iterative procedure was used to improve the
decision aid. The core components of the decision aid
are described in Table 1. Respondents in the interven-
tion group will be asked to view the decision aid.
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Control condition
A placebo control condition was designed consisting of
general information on self-testing. An existing control
condition was not available, since there is no usual care
in self-testing. Our intervention is the first decision aid
that aims at people with an intention towards self-testing,
and, to the best of our knowledge, is the first non-com-
mercial website that provides test specific information on
cholesterol and diabetes self-testing. The control condi-
tion will consist of a pdf file of one page which gives gen-
eral information on self-testing (definition of a self-test
and the types of self-tests that are available). It does not
include test specific information or interactive elements
that are included in the original decision aid since these
are distinguishing features of our decision aid.
Methods of data collection
An overview of all questionnaires and measures is pro-
vided in Table 2 and Figure 1.
Questionnaire 1 will be sent to a random sample of
the Flycatcher panel and is aimed at selecting consu-
mers with an intention towards self-testing for diabetes
or cholesterol. The questionnaire will consist of ques-
tions on personal characteristics (including medical his-
tory of cardiovascular disease and diabetes, and risk
factors), and intention towards doing a cholesterol or
diabetes self-test. (Additional file 1). A translation of the
questionnaires (originally in Dutch) is provided in the
additional data files.
Questionnaire 2 will be sent after participants have
been assigned to the intervention or control condition
and have been exposed to this condition. Participants
with an intention to do a cholesterol self-test will
receive questions on cholesterol self-testing (Additional
file 2), participants with an intention to do a diabetes
self-test will receive a similar questionnaire, but addres-
sing the diabetes self-test (Additional file 3).
Three months after participants have viewed the deci-
sion aid or the control condition, they will be sent ques-
tionnaire 3 (Additional file 4), which includes questions
on self-test use in the past 3 months, intention towards
doing a self-test, visiting a doctor or changing lifestyle.
Measures
Primary outcome
Knowledge Knowledge questions are based on the
themes that are addressed in the decision aid. It includes
questions on the condition, indications for testing, such
as symptoms and risk factors, what the test measures,
how to interpret the test result, and questions on the
validity of the self-test. These aspects of self-testing
were deemed important by health professionals as well
as indicated by end-users [9](Grispen et al: Quality and
use of consumer information provided with home test
kits: Room for improvement, submitted). This knowl-
edge quiz consists of 20 true/false statements. Knowl-
edge questions are test specific, and differ between the
cholesterol and diabetes self-test.
Secondary outcome measures
Intention Intention to do a self-test in general and the
intention to do a self-test for diabetes and cholesterol.
Intention will be assessed with a single question using a
Table 1 Core components of the decision aid
Homepage The homepage gives an introduction on how to use the website, and an explanation about the contents of the
website. Visitors are asked to read the disclaimer, and a warning is given that the information provided on the
website is not suitable for people who are already being treated for diabetes or cardiovascular disease.
General information on self-
testing
General information on self-testing, including information on the different kinds of self-tests, the reliability of self-
tests in general and eleven cues what to check before doing a self-test.
Information on cholesterol
self-testing
Information on cholesterol self-testing: information on risk factors for cardiovascular disease, the role of cholesterol as
a risk factor in cardiovascular disease, an interactive tool to determine personal risk for cardiovascular disease,
information on the different kinds of cholesterol tests (tests for total cholesterol and HDL cholesterol), how these
self-tests have to be performed, and what to do with the test result, including advise when to see a doctor, and
information on lifestyle changes.
Information on diabetes self-
testing
Information on diabetes self-testing, similar to the information related to the cholesterol self-test, including an
interactive tool to assess your personal risk for developing diabetes.
FAQ Frequently asked questions
Value clarification tool An interactive tool to weigh the pros and cons of self-testing. This tool first shows 12 propositions on self-testing, of
which six represent advantages of a self-testing, and the other 6 the disadvantages of self-testing. Examples of these
propositions are: ‘I think it is an advantage that I can do the test whenever I want to’, or ‘I think that it is a
disadvantage of self-testing that I have to get a blood sample myself’. People can indicate whether they agree,
disagree or feel neutral about these propositions. When they indicate they agree with a proposition, the weighing
scales depicted next to the propositions starts shifting towards doing a self test or not doing a self-test. After
respondents have filled out all the propositions, they are asked which propositions are most important to them.
They are explained that the tool is not meant to give an advise on whether to do a self-test or not, but is aimed at
clearing out their personal values on self-testing.
Sitemap, disclaimer and contact information.
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5-point Likert scale with answering options ranging
from 1 = ‘definitely not’ to 5 = ‘definitely will’. Further,
intention to visit a doctor and intention to change life-
style will be assessed.
Intention will also be measured using the stages of
change algorithm [27]. Stages of change will give more
detailed insight in the strength of the participants’ inten-
tion towards doing a self-test and will be measured by
asking participants in what time frame they think they
will perform a self-test.
Attitude Attitude towards self-testing for diabetes or
cholesterol will be measured using a four item scale
developed by Marteau [26]. Participants are asked to
respond to the following questions on a 7-point Likert
scale: I think self-testing is: harmful–beneficial; unim-
portant–important; bad thing–good thing; unpleasant–
pleasant. Responses are used to classify people as having
a positive or a negative attitude. Scores range from 4 to
28, with higher scores referring to a more positive atti-
tude towards self-testing. Whether the participant has a
positive or negative attitude towards self-testing will be
determined using the median of the scores of the parti-
cipants [26].
Ambivalence Felt ambivalence will be assessed using a 3
item scale as described by Priester and Petty [24].
Psychosocial determinants Possible determinants of
self-test use were derived from the Health Belief Model
(HBM) [16], as well as several concepts of the Theory of
Planned Behavior (TPB) [17] and will be assessed after
participants have viewed the decision aid or control
condition.
Behaviour Behaviour will be measured 3 months after
the intervention. Participants will be asked whether they
have performed a self-test for cholesterol or diabetes,
and whether they have visited a doctor or have changed
their lifestyle in the past 3 months, in response to hav-
ing viewed the decision aid. If they have performed a
self-test, they will be asked what the result of the self-
test was (normal test result, abnormal test result) and
the actions taken based on this test result.
Process evaluation
Message acceptance will be measured on an eight item
scale, for example, ‘The information provided on the
website is very realistic/realistic/neutral/not realistic/not
realistic at all’ [29]. Participants will be asked to com-
ment on the strong and weak features of the decision
aid. Weblog files of each participant will be collected to
assess use of the website, time spent on the website and
use of each page of the website.
Sample size
According to a Cochrane review by O’Connor et al. on
the efficacy of decision aids, there is an average absolute
increase of 15% in knowledge scores when decision aids
are compared to usual care. When more detailed deci-
sion aids are compared to simpler decision aids, knowl-
edge increases with 5% [11]. Since we will compare our
Table 2 Outcome measures and timing of data collection
Construct Measures No. of items Questionnaire*
Primary outcomes
Knowledge Knowledge questionnaire based on information provided in the
decision aid
20 Statements (True/false/don’t
know)
2
Secondary outcomes
Attitude Marteau [26] 4 1,2
Ambivalence Felt ambivalence [24] 3 1,2
Follow-up behaviour Uptake of self-tests, visiting a doctor, changing lifestyle. 7 3
Intention Intention towards self-testing, seeing a doctor. 2 1,2,3
Intention towards changing lifestyle 1 2,3
Stages of change [27] 1 1,2,3
Psychosocial
determinants
Perceived benefits and barriers 14 2
Self-efficacy 3 2
Response-efficacy 4 2
Perceived susceptibility/risk perception [28] 3 1,2,3
Cues to action 1 2
Perceived severity 1 2
Anticipated regret 1 2
Moral obligation 2 2
Subjective norm 1 2
*Questionnaire 1: baseline. Questionnaire 2: directly after seeing intervention or control condition. Questionnaire 3: three months after viewing intervention or
control condition
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decision aid to general, non test specific information on
self-testing, we expect an increase in knowledge of 15%
(intervention group knowledge score 70%, control group
55%). Our sample size will be based on a power of 80%
to detect a hypothesized increase in knowledge of 15%
at a significance level of 5% (two-sided). Power analysis
showed 175 respondents would be needed in each of
the four groups [30]. Based on previous research, a com-
pletion rate of 60% on the first questionnaire, and 80%
on the second questionnaire is expected [3]. Intention
Questionnaire 1 
Flycatcher Panel 
Random selection 
Selection of participants with an 
intention to do a cholesterol or 
diabetes self-test 
Age > 18 years 
Intention towards 
doing a diabetes 
self-test 
Intention towards 
doing a cholesterol 
self-test 
Two weeks Two weeks 
Randomisation Randomisation 
Intervention Control Intervention Control 
Questionnaire 2 
Three months 
Questionnaire 3 
Figure 1 Selection of participants and randomization.
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towards doing a cholesterol and/or a diabetes self-test in
2008 was 42%. Based on these results, a minimum of
3472 respondents would have to be invited for the first
questionnaire. Since we do not know intention rate in
2011, and an unknown number of participants will be
excluded because of having cardiovascular disease or
diabetes, we decided to invite 6000 panel members for
the first questionnaire.
Statistical analysis
Knowledge will be treated as primary outcome measure,
whereas intention, attitude, ambivalence and psychoso-
cial variables are the secondary outcome measures. To
compare knowledge levels and level of ambivalence
between the intervention and control group, we will use
linear regression analysis. The effect of the decision aid
on the psychosocial factors that predict self-test use will
be assessed using logistic regression analysis. Follow-up
behaviour after 3 months will be compared using logis-
tic regression analysis.
Based on the method proposed by Marteau and col-
leagues, informed choice will be measured by combining
the constructs knowledge, attitudes and behaviour into a
composite measure of informed decision making [26].
Informed choice in our study will be defined as having
sufficient knowledge, and attitude being in line with
intention (positive attitude and a positive intention to
do a self-test, or a negative attitude and a negative
intention to self-test). As a cut off point for having suffi-
cient knowledge, a score of 50% (number of correct
answered questions 10 or above) will be considered.
Individual scores will be corrected for guessing using
Abbotts’ formula [31,32]. A positive intention towards
self-testing is defined as a participant indicating to
maybe, probably or definitely consider performing a
self-test in the future. To classify participants as having
a positive or negative attitude towards self-testing, the
median score will be used. The median score of the par-
ticipants and scores above will indicate a positive atti-
tude, whereas scores below the median score will be
considered as a negative attitude [26]. The percentage of
people with an informed choice in the control and inter-
vention group will be compared using logistic regression
analysis.
Discussion
This paper describes the protocol for a randomised con-
trolled trial to evaluate the effect of an online decision
aid for self-testing on diabetes and cholesterol. Since
self-testing on these conditions can be beneficial but can
have negative implications as well, the goal of the deci-
sion aid ‘zelftestwijzer’ was not to increase or decrease
uptake of these tests, but to enhance knowledge levels
and to guide the decision making process. Self-testing
uptake in the past often seemed to be associated with
offering of free tests and media campaigns stressing the
importance of testing, and consumers responding quite
straightforward, being curious about testing and wanting
to be reassured on their health status [9]. Although
these strategies seemed to increase uptake levels, consu-
mers will often not have considered important pitfalls of
self-testing [3]. Also, consumers with an intention
towards self-testing experience several barriers to self-
testing, especially a lack of knowledge on interpreting
the results (Grispen et al: An intention to self-testing: a
qualitative study regarding consumers’ considerations
and information needs about self-testing, submitted).
For this reason, the primary outcome of this study is
knowledge of on self-testing. We expect knowledge
levels of participants who have viewed the decision aid
to increase. Being aware of the pitfalls of self-testing,
but also of the positive effects of self-testing, consumers
should be enabled to make a choice regarding self-test-
ing they think is the best choice for them. We expect
levels of informed choice to increase, and levels of
ambivalence to decrease. We will measure actual uptake
of self-tests 3 months after viewing the decision aid, to
assess if there are changes in uptake of tests between
the intervention and the control group.
Strengths and limitations
The online decision aid has been developed in a thor-
ough, iterative process, and is considered to be a sound
and user-friendly provider of information on self-testing.
By using an Internet panel, the online decision aid can
be tested among a large group of individuals with an
intention towards self-testing. The use of individual
weblog files will provide the opportunity to assess how
long each participant has viewed the decision aid, and
which pages of the decision aid they have visited.
Most decision aid evaluation studies compare the
decision aid to usual care, or to simpler versions of the
decision aid. Since there is no usual care in self-testing,
we decided to provide the control group with a control
intervention that consists of only general information on
self-testing, without any specific information on diabetes
and cholesterol. This minimal information is the same
information as was already provided in the instruction
section of the baseline questionnaire, so this is the maxi-
mum contrast in information provided between inter-
vention and control group possible. The fact that the
participants were blind for the trial conditions is a
strength, minimising the Hawthorne effect.
The measure of informed choice often includes actual
behaviour instead of intention. In our study, measuring
behaviour (uptake of tests after seeing the information)
would ask for selecting consumers who are at the point
of purchasing a self-test. Since self-tests are provided in
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several websites and shops, it would be almost impossi-
ble to gather a group of consumers large enough for a
trial. Besides these practical reasons, the fact that we
invited consumers who are still considering doing a test,
instead of being in a shop, at the at the point of pur-
chasing the test, gives consumers more time to read
information on self-testing and thoroughly consider the
pros and cons of these tests. Therefore, we chose to
invite consumers with a positive intention towards self-
testing to view the decision aid, although we know these
people are not actually faced with a decision that needs
to be made.
Inviting consumers who are not faced with an actual
decision that needs to be made can affect the generalisa-
bility of our data. Participants in our trial might read
other information on the decision aid than consumers
who are close to buying a self-test. On the other hand,
participants are encouraged to read the complete deci-
sion aid, and know they will receive an incentive if they
have viewed the decision aid and have filled out ques-
tions in the questionnaire provided afterwards. The
actual use of the decision aid will also be affected by its
usability and attractiveness to visitors. Although the
decision aid was developed using usability tests to assess
user friendliness of the decision aid, the results of the
process evaluation such as information on message
acceptance and weblog files, will be of use for optimis-
ing and implementing the decision aid after the trial.
Additional material
Additional file 1: Questionnaire 1 (translated from Dutch).
Additional file 2: Questionnaire 2 Cholesterol (translated from
Dutch).
Additional file 3: Questionnaire 2 Diabetes (translated from Dutch).
Additional file 4: Questionnaire 3 (translated from Dutch).
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